Showing results (551-560 of 612) with videos related to

Sort By:
Pageof 62
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 28, 2021
The impact of ocrelizumab on health-related quality of life in individuals with multiple sclerosisBonnie I Glanz, Jonathan Zurawski, Emily C Casady, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 5, 2026
T lymphopenia in multiple sclerosis patients treated with ofatumumab: Even with consideration for CD3 + CD20+ cellsMasami Tanaka, Masako Kinoshita, Keiko Tanaka
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 28, 2020
Long-term worsening of different body functions in persons with progressive multiple sclerosisMarco Kaufmann, Claude Vaney, Laura Barin, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 11, 2022
Prediction of high and low disease activity in early MS patients using multiple kernel learning identifies importance of lateral ventricle intensityClaudia Chien, Moritz Seiler, Fabian Eitel, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 8, 2020
The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosisCecilia Smith Simonsen, Heidi Øyen Flemmen, Trine Lauritzen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 22, 2021
Prioritizing the healthcare access concerns of Canadians with MSJulie Pétrin, Mary Ann McColl, Catherine Donnelly, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 27, 2019
Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosisMonica Margoni, Francesca Rinaldi, Silvia Miante, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 28, 2020
Fatal COVID-19 in an MS patient on natalizumab: A case reportKathryn Rimmer, Rebecca Farber, Kiran Thakur, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 26, 2019
Effect of different doses of gadolinium contrast agent on clinical outcomes in MSNathalie Ackermans, Carolyn Taylor, Roger Tam, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 24, 2018
The topographical model of MS: Empirical evaluation of the recapitulation hypothesisBenjamin M Laitman, Karin Cook, Madhuri Fletcher, et al.
Pageof 62